The trial was tiny, just 16 patients, but it’s eliciting a sentiment not normally associated with this brutal disease of ...

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

These vaccines work by stimulating the body's immune response against cancer cells, often by training immune cells (like T ...

A new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...

A new study published in the journal Nature emphasizes the promise of a personalized vaccine, autogene cevumeran, in treating ...

Researchers associated with the New York-based Memorial Sloan Kettering Cancer Center have obtained positive results in the ...

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...

Through this study, we aim to offer a new, innovative treatment to patients,” medical oncologist Dr. John Lenehan said.